These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
843 related items for PubMed ID: 8768488
1. [Role of cytokines in resistance and pathology in Trypanosoma cruzi infection]. Laucella SA, Rottenberg ME, de Titto EH. Rev Argent Microbiol; 1996; 28(2):99-109. PubMed ID: 8768488 [Abstract] [Full Text] [Related]
2. [TH1 response in the experimental infection with Trypanosoma cruzi]. Cardoni RL, Antúnez MI, Abrami AA. Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248 [Abstract] [Full Text] [Related]
3. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Muñoz-Fernández MA, Fernández MA, Fresno M. Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373 [Abstract] [Full Text] [Related]
5. Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Zhang L, Tarleton RL. Exp Parasitol; 1996 Nov; 84(2):203-13. PubMed ID: 8932770 [Abstract] [Full Text] [Related]
7. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice. Basso B, Cervetta L, Moretti E, Carlier Y, Truyens C. Vaccine; 2004 May 07; 22(15-16):1868-72. PubMed ID: 15121297 [Abstract] [Full Text] [Related]
9. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Zhang L, Tarleton RL. Eur J Immunol; 1996 Jan 07; 26(1):102-9. PubMed ID: 8566051 [Abstract] [Full Text] [Related]
10. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. Eur J Immunol; 1992 Oct 07; 22(10):2501-6. PubMed ID: 1396957 [Abstract] [Full Text] [Related]
11. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi. Hoft DF, Lynch RG, Kirchhoff LV. J Immunol; 1993 Dec 15; 151(12):7038-47. PubMed ID: 8258708 [Abstract] [Full Text] [Related]
12. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase. Guedes PM, Veloso VM, Afonso LC, Caliari MV, Carneiro CM, Diniz LF, Marques-da-Silva EA, Caldas IS, Do Valle Matta MA, Souza SM, Lana M, Chiari E, Galvão LM, Bahia MT. Vet Immunol Immunopathol; 2009 Jul 15; 130(1-2):43-52. PubMed ID: 19211152 [Abstract] [Full Text] [Related]
13. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile. Sathler-Avelar R, Vitelli-Avelar DM, Massara RL, Borges JD, Lana M, Teixeira-Carvalho A, Dias JC, Elói-Santos SM, Martins-Filho OA. Scand J Immunol; 2006 Nov 15; 64(5):554-63. PubMed ID: 17032249 [Abstract] [Full Text] [Related]
14. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. Abrahamsohn IA, Coffman RL. J Immunol; 1995 Oct 15; 155(8):3955-63. PubMed ID: 7561103 [Abstract] [Full Text] [Related]
15. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. Miyazaki Y, Hamano S, Wang S, Shimanoe Y, Iwakura Y, Yoshida H. J Immunol; 2010 Jul 15; 185(2):1150-7. PubMed ID: 20562260 [Abstract] [Full Text] [Related]
16. Suppressive action of melatonin on the TH-2 immune response in rats infected with Trypanosoma cruzi. Santello FH, Frare EO, dos Santos CD, Caetano LC, Alonso Toldo MP, do Prado JC. J Pineal Res; 2008 Oct 15; 45(3):291-6. PubMed ID: 18373553 [Abstract] [Full Text] [Related]
17. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R. Clin Ter; 2006 Oct 15; 157(4):377-86. PubMed ID: 17051976 [Abstract] [Full Text] [Related]
18. Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-gamma and S100beta protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi. Bombeiro AL, D'Império Lima MR, Chadi G, Alvarez JM. Neuroimmunomodulation; 2010 Oct 15; 17(2):67-78. PubMed ID: 19923851 [Abstract] [Full Text] [Related]
19. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Marinho CR, Nuñez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, Bucci DZ, Sardinha LR, Lima MR, Alvarez JM. Scand J Immunol; 2007 Oct 15; 66(2-3):297-308. PubMed ID: 17635807 [Abstract] [Full Text] [Related]
20. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. Malvezi AD, Cecchini R, de Souza F, Tadokoro CE, Rizzo LV, Pinge-Filho P. FEMS Immunol Med Microbiol; 2004 May 01; 41(1):69-77. PubMed ID: 15094169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]